Prepared by: Dr. Mohammad Shaikhani University of Sulaimani College of Medicine. Dept of Medicine.

Slides:

Advertisements

Similar presentations

Results of a smoking cessation intervention programme in the workplace: lessons learnt Dr. Timea TOTH Ruzsas E, Biro B, Olajos A, Nikl A, Jelencsics Zs.

Advertisements

Encouraging cessation intervention to become routine practice for people working with Aboriginal and Torres Strait Islander clients Toni Mason Aboriginal.

Results Introduction Tobacco use is the leading preventable cause of death in Wisconsin and the United States. Given the risk of smoking initiation during.

Nicotine Addiction Pharmacy Practice II Winter 2005.

STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.

Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.

Tobacco & Cancer. Tobacco Use And Cancer Tobacco use, the most preventable cause of death in our society, accounts for at least 30% of all cancer deaths.

Chapter 8—Caffeine & Nicotine Robert M. Julien Presentation By: Tamyra Frazier & Sarah Massamore.

ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine

Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.

Key Public Health issues of smoking Passive smoking in home, car, workplace, restaurants etc. Self- induced disease and cost of smoking related diseases.

Presinted by :Shahd Amer.  Tobacco ads may make you feel like everyone is doing it but they are not.  Only about 28% of high school students smoke.

Prevention strategies

Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.

Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.

Basics: 2As & R Clinical Intervention Artwork by Nancy Z. © 2010 American Aca0emy of Pediatrics (AAP) Children's Art Contest. Support for the 2010 AAP.

Smoking in Special Populations: Psychiatric and Alcohol Use Disorders Eric Heiligenstein, M.D. Clinical Director, Psychiatry Service University Health.

Introduction to Smoking Cessation MSSM III Edward Anselm, M.D. Assistant Professor of Medicine Icahn School of Medicine at Mount Sinai Medical Director,

SMOKING CESSATION Leading Preventable Cause of Death 400,000 to 500,000 deaths per year in USA 3 Million deaths world wide 1 of every 6 deaths in USA Directly.

Establish and Sustain Tobacco Cessation Programs.

California Smokers’ Helpline Center for Tobacco Cessation Kirsten Hansen, MPP Curriculum Development Manager.

Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.

Tobacco usage Smoking prevalence 1 in 5 Americans smoke  21% of adults > 18 years  (23.9%men, 18% women)  AND  22% high school students  (The.

Using Behaviour Change Technique (BCT) analysis to improve fidelity to treatment manuals in smoking cessation: A case study Billie Bonevski, Laura Twyman,

The Ohio Partners for Smoke-Free Families 5A’s

Establish and Sustain Tobacco Cessation Programs

Copyright Alcohol Medical Scholars Program1 The Relationships Between Alcohol Use Disorders and Nicotine Dependence Margaret Rukstalis, M.D. University.

20th Century World War 1 (soldier’s relief) 1920’s beginning of heavy marketing World War II Marlboro Man 1964 Smoking linked to cancer 1971 advertisements.

Quittin’ Time: Helping Employees Become Tobacco-free June 2005.

Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

What we need to know about smoking & tobacco addiction.

Smoking Cessation: the pharmacotherapeutic and non-pharmacotherapeutic approaches to addictive behavior Andrea C. McKean February 22, 2007.

Nicotine Holley Williamson and Rachel Martinez. Addiction Chewed, Smoked, or Inhaled Absorbed within 7 Seconds of inhalation Nicotine molecule shaped.

TOBACCO CONTROL INITIATIVE HCSD Disease Management Program Quarterly Meeting April 26, 2005 Sarah Moody Thomas, PhD Statewide Clinical Lead.

QUITTING SMOKING… WHY YOU SHOULD DROP THE HABIT AND HOW YOUR LIFE WILL IMPROVE IF YOU DO BY: BRADYN MUSICH.

Cherokee Health Systems Encouraging Tobacco Cessation Through the Five A’s: Ask, Advise, Assess, Assist, Arrange Mary Clare Champion, Ph.D. Cherokee Health.

Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Linking Together to.

PRINCIPLES OF DRUG ADDICTION TREATMENT Dr. K. S. NJUGUNA.

Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.

Citizens of Harvestland Against Tobacco (CHAT) Coalition Harvestland, Missouri Teaming Up To End Tobacco Use.

SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.

Tobacco & SMI: Bending the Deadly Curve Gregory A. Miller, M.D. Mary Barber, M.D. Maxine Smalling, R.N. New York State Statewide Grand Rounds January 21,

Policies for helping smokers who cannot quit: a prerequisite for maximum prevention of tobacco induced diseases Lars M. Ramström Institute for Tobacco.

Physiology and Behaviour of Withdrawal Syndrome Idrees M, Hussain A, Hyman A, Humphries R & Hughes E. Introduction: Chronic administration of certain drugs.

Better Health. No Hassles. Nicotine Dependence Addiction to tobacco products. Nicotine produces physical and mood-altering effects that are temporarily.

Hazelden Your Next Step Tobacco Recovery Program National Conference on Tobacco or Health Presented by Barry McMillen, MA, LADC, TAS.

Effectiveness of interventions to aid smoking cessation Robert West University College London September 2008.

SMOKING CESSATION: THE MINIMAL CONTACT INTERVENTION.

Emerging Neuronal Nicotinic Receptor Targets Marina Picciotto Department of Psychiatry Yale University School of Medicine.

Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.

Stress and Health notes 14-4 (obj.18-20). A.) Regular religious attendance has been a reliable predictor of a longer life span with a reduced risk of.

Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.

1 Addiction to tobacco Robert West University College London November

Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.

Full Circle: A Holistic Cessation Intervention Serving American Indians in Oklahoma Sally Carter, MSW, Oklahoma State Department of Health; Cynthia Tainpeah,

Conclusions and Awards

Smoking Cessation Medication

Anita R. Webb, PhD JPS Family Medicine Residency

screening, brief intervention, and referral to treatment

Assistant professor Family Medicine - Suez Canal University

Module: Tobacco and Adolescents

Why and How to Quit Smoking

Forming a Tobacco Addiction

Operant Conditioning – Chapter 8 Some Practical Applications…

Smoking cessation Felix K. Karthik.

ABCs of Behavioral Support

Smoking cessation pt1 Mohammad AbuAssi.

Tobacco Cessation for Primary Care Providers

What is it? What causes it? What can we do about it?

Presentation transcript:

Prepared by: Dr. Mohammad Shaikhani University of Sulaimani College of Medicine. Dept of Medicine.

Introduction:  Smoking is responsible for the death of 1/10 adults worldwide, or 5 million deaths /year.  50% will eventually die, mostly avoided by quiting.  The prevalence;18% - 30%, 50% in China& rising in developing countries.  Tobacco is one of the few causes of preventable death increasing globally.  In West, decreasing.  Although the gap is narrowing specially in adolescents, males more than females overall,

Determinants of tobacco use:  Tobacco dependence results from several closely interrelated factors:  Neurochemical  Environmental  Individual

Neurochemical determinants:  Nicotine is the critical reinforcing component.  Nicotinic Ach receptors have reinforcing effects.  Nicotine produces a sustained effect on dopamine release in the nucleus accumbens& induce motivational / reinforcing properties.  Medications that act on glutamate or GABA systems hold the promise of reducing drug cravings or avoiding relapse.

Enviromental determinants:  Availability.  Low cost.  Advertising specially to thee youth.  Friend, Peer pressure.

Individual determinants:  Individuals are not at equal risk of tobacco dependence.  Genetic component:  Psychiatric disorders *2- 3, more in schizophrenia, depression, drug addiction.  Tobacco may improve the psychiatric conditions or reduce the side effects of some psychiatric medications &mimic the effects of antidepressants,as tobacco smoke contains chemical substances that inhibit monoamine oxidase A/B.  This may explain the increased risk of depression for 6 months or longer following smoking cessation.

Management of tobacco dependence:  Adequate evaluation of the patient & environment.  Since 70% of smokers see a physician/year, physicians &health professionals have a substantial opportunity to influence smoking behaviour.  The essential features of smoking cessation treatment 5 As:  Ask about smoking at every opportunity  Advise all smokers to stop  Assess their willingness to stop  Assist the smoker to stop  Arrange follow-up  Success is often obtained only after several attempts& HCWs should adopt the same attitude as with other chronic disorders & should provide support over a long period.

Management: overall  2 approaches proven effective:  Pharmacotherapy  Nonpharmacologic interventions  Best results obtained when the 2 combined& pharmacotherapy increase chance of initiating / maintaining abstinence 23-fold& should be used more extensively.

Single-choice Qs: 1. The 1 st -line management pharmacological of tobacco dependence include all except: A. Tricyclic antidepressants. B. Benzodiazepines. C. Nicotine replacement. D.Buprpion. E.Varnecilin.

Single-choice Qs: 2. Nicotine replacement therapy is given in all these forms except: A. Gums. B.Inhaler. C.Lozenges. D. Patch. E.Suppositories.

Single-choice Qs: 3. The following are among non- pharmacological interventions to enhance smoking quitting except: A.Physian advice. B.Self-helpmterials. C. Social support. D.Hypnotherapy. E. Individual, group & telephone counseling.